ACE2 and COVID-19: Although ACE2 is the cellular entry point, there is little evidence that genetic variation in ACE2 is singularly responsible for COVID-19 susceptibility (Ellinghaus et al., 2020; Pairo-Castineira et al., 2020; Shelton et al., 2020).